Amedeo Smart

Free Medical Literature Service


 

Amedeo

Breast Cancer

  Free Subscription

23.10.2017

1 AJR Am J Roentgenol
1 Am J Clin Oncol
1 Am J Clin Pathol
1 Am J Epidemiol
8 Ann Oncol
2 Ann Surg Oncol
1 Anticancer Res
2 BMC Cancer
2 Breast Cancer
1 Breast Cancer (Dove Med Press)
8 Breast Cancer Res Treat
1 Breast J
2 Cancer
1 Carcinogenesis
5 Clin Breast Cancer
1 Gene
3 Int J Cancer
4 Int J Oncol
2 J Clin Oncol
2 J Natl Cancer Inst
2 Lancet Oncol
2 N Engl J Med
1 Nat Rev Clin Oncol
11 Oncol Rep
9 PLoS One
2 Radiology
1 Radiother Oncol
1 Science



    AJR Am J Roentgenol

  1. LEE CS, Moy L, Friedewald SM, Sickles EA, et al
    Harmonizing Breast Cancer Screening Recommendations: Metrics and Accountability.
    AJR Am J Roentgenol. 2017 Oct 18:1-5. doi: 10.2214/AJR.17.18704.
    >> Share


    Am J Clin Oncol

  2. FIGUEIRA PVG, Haddad CAS, de Almeida Rizzi SKL, Facina G, et al
    Diagnosis of Axillary Web Syndrome in Patients After Breast Cancer Surgery: Epidemiology, Risk Factors, and Clinical Aspects: A Prospective Study.
    Am J Clin Oncol. 2017 Oct 17. doi: 10.1097/COC.0000000000000411.
    >> Share


    Am J Clin Pathol

  3. GULBAHCE HE
    Impact of 2013 American Society of Clinical Oncology/College of American Pathologists Guidelines on HER2 Fluorescent In Situ Hybridization Testing in Breast Cancers : Experience From a National Reference Laboratory.
    Am J Clin Pathol. 2017;148:308-313.
    >> Share


    Am J Epidemiol

  4. KRIEGER N, Jahn JL, Waterman PD, Chen JT, et al
    Breast Cancer Estrogen Receptor by Biological Generation: US Black & White Women, Born 1915-1979.
    Am J Epidemiol. 2017 Sep 20. doi: 10.1093.
    >> Share


    Ann Oncol

  5. CURIGLIANO G, Burstein HJ, Winer EP, Gnant M, et al
    Reply to "The St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology" by Kirova et al.
    Ann Oncol. 2017 Sep 25. doi: 10.1093.
    >> Share

  6. BURUGU S, Gao D, Leung S, Chia SK, et al
    LAG-3+ tumor infiltrating lymphocytes in breast cancer: clinical correlates and association with PD-1/PD-L1+ tumors.
    Ann Oncol. 2017 Sep 25. doi: 10.1093.
    >> Share

  7. FRIBBENS C, Garcia Murillas I, Beaney M, Hrebien S, et al
    Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer.
    Ann Oncol. 2017 Oct 4. doi: 10.1093.
    >> Share

  8. NUCIFORO P, Pascual T, Cortes J, Llombart-Cussac A, et al
    A predictive model of pathological response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade.
    Ann Oncol. 2017 Oct 12. doi: 10.1093.
    >> Share

  9. KIROVA YM, Carroll S, Fourquet A, Offersen B, et al
    The St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology.
    Ann Oncol. 2017 Sep 22. doi: 10.1093.
    >> Share

  10. HAN HS, Dieras V, Robson M, Palacova M, et al
    Veliparib With Temozolomide or Carboplatin/Paclitaxel Versus Placebo With Carboplatin/Paclitaxel in Patients With BRCA1/2 Locally Recurrent/Metastatic Breast Cancer: Randomized Phase II Study.
    Ann Oncol. 2017 Sep 29. doi: 10.1093.
    >> Share

  11. NABIEVA N, Kellner S, Fehm T, Haberle L, et al
    Patient and tumor characteristics and their influence on early therapy persistence with letrozole in postmenopausal patients with early breast cancer.
    Ann Oncol. 2017 Oct 10. doi: 10.1093.
    >> Share

  12. LAMBERTINI M, Goldrat O, Ferreira AR, Dechene J, et al
    Reproductive potential and performance of fertility preservation strategies in BRCA-mutated breast cancer patients.
    Ann Oncol. 2017 Oct 10. doi: 10.1093.
    >> Share


    Ann Surg Oncol

  13. VIGNES S, Brorson H
    Comment on "Clinical and Psychosocial Outcomes of Vascularized Lymph Node Transfer for the Treatment of Upper Extremity Lymphedema After Breast Cancer Therapy".
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6124.
    >> Share

  14. KESKEY RC, LaJoie AS, Sutton BS, Kim IK, et al
    Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
    Ann Surg Oncol. 2017 Oct 16. doi: 10.1245/s10434-017-6094.
    >> Share


    Anticancer Res

  15. GRZEGRZOLKA J, Wojtyra P, Biala M, Piotrowska A, et al
    Correlation Between Expression of Twist and Podoplanin in Ductal Breast Carcinoma.
    Anticancer Res. 2017;37:5485-5493.
    >> Share


    BMC Cancer

  16. JAHN B, Rochau U, Kurzthaler C, Hubalek M, et al
    Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online.
    BMC Cancer. 2017;17:685.
    >> Share

  17. KIM HM, Lee J, Koo JS
    Clinicopathological and prognostic significance of programmed death ligand-1 expression in breast cancer: a meta-analysis.
    BMC Cancer. 2017;17:690.
    >> Share


    Breast Cancer

  18. OGITA M, Nagura N, Kawamori J, In R, et al
    Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: a retrospective cohort study.
    Breast Cancer. 2017 Oct 19. doi: 10.1007/s12282-017-0808.
    >> Share

  19. TOYODA Y, Tabuchi T, Nakayama T, Hojo S, et al
    Trends in the clinical stage distribution of breast cancer in Osaka, Japan.
    Breast Cancer. 2017 Oct 12. doi: 10.1007/s12282-017-0807.
    >> Share


    Breast Cancer (Dove Med Press)

  20. RANGEL N, Villegas VE, Rondon-Lagos M
    Profiling of gene expression regulated by 17beta-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines.
    Breast Cancer (Dove Med Press). 2017;9:537-550.
    >> Share


    Breast Cancer Res Treat

  21. MORDANG JJ, Gubern-Merida A, Bria A, Tortorella F, et al
    The importance of early detection of calcifications associated with breast cancer in screening.
    Breast Cancer Res Treat. 2017 Oct 17. doi: 10.1007/s10549-017-4527.
    >> Share

  22. ADACHI Y, Yoshimura M, Nishida K, Usuki H, et al
    Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
    Breast Cancer Res Treat. 2017 Oct 12. doi: 10.1007/s10549-017-4532.
    >> Share

  23. BERNSTEIN V, Ellard SL, Dent SF, Tu D, et al
    A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.
    Breast Cancer Res Treat. 2017 Oct 13. doi: 10.1007/s10549-017-4538.
    >> Share

  24. CHOI BH, Choi N, Kim MY, Yang JH, et al
    Usefulness of abbreviated breast MRI screening for women with a history of breast cancer surgery.
    Breast Cancer Res Treat. 2017 Oct 13. doi: 10.1007/s10549-017-4530.
    >> Share

  25. FIETZ T, Zahn MO, Kohler A, Engel E, et al
    Routine treatment and outcome of breast cancer in younger versus elderly patients: results from the SENORA project of the prospective German TMK cohort study.
    Breast Cancer Res Treat. 2017 Oct 13. doi: 10.1007/s10549-017-4534.
    >> Share

  26. SCHON K, Tischkowitz M
    Clinical implications of germline mutations in breast cancer: TP53.
    Breast Cancer Res Treat. 2017 Oct 16. doi: 10.1007/s10549-017-4531.
    >> Share

  27. MALMGREN JA, Mayer M, Atwood MK, Kaplan HG, et al
    Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.
    Breast Cancer Res Treat. 2017 Oct 16. doi: 10.1007/s10549-017-4529.
    >> Share

  28. LUBINSKI J, Marciniak W, Muszynska M, Huzarski T, et al
    Serum selenium levels predict survival after breast cancer.
    Breast Cancer Res Treat. 2017 Oct 17. doi: 10.1007/s10549-017-4525.
    >> Share


    Breast J

  29. KHOURY A, Parihar V, O'steen L, Cherabuddi K, et al
    Pertuzumab and trastuzumab infusion related cytokine release syndrome in a chemotherapy naive patient with metastatic breast cancer.
    Breast J. 2017 Oct 13. doi: 10.1111/tbj.12943.
    >> Share


    Cancer

  30. WALLACE AS, Keene KS, Williams CP, Jackson BE, et al
    Radiation therapy utilization in Medicare beneficiaries with early-stage breast cancer.
    Cancer. 2017 Oct 20. doi: 10.1002/cncr.30989.
    >> Share

  31. GUTIERREZ BARRERA AM, Fouad TM, Song J, Webster R, et al
    BRCA mutations in women with inflammatory breast cancer.
    Cancer. 2017 Oct 17. doi: 10.1002/cncr.31069.
    >> Share


    Carcinogenesis

  32. PORE SK, Hahm ER, Latoche JD, Anderson CJ, et al
    Prevention of breast cancer-induced osteolytic bone resorption by benzyl isothiocyanate.
    Carcinogenesis. 2017 Oct 11. doi: 10.1093.
    >> Share


    Clin Breast Cancer

  33. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
    Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
    >> Share

  34. WU J, Wang S, Liu F, Li S, et al
    Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
    >> Share

  35. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
    Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
    >> Share

  36. MANN JM, Wu X, Christos P, Nagar H, et al
    The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
    Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
    >> Share

  37. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
    The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
    Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
    >> Share


    Gene

  38. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    >> Share


    Int J Cancer

  39. SUROWY H, Varga D, Burwinkel B, Marme F, et al
    A low frequency haplotype spanning SLX4/FANCP constitutes a new risk locus for early-onset breast cancer (<60 years) and is associated with reduced DNA repair capacity.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31105.
    >> Share

  40. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    >> Share

  41. YU J, Wang X, Lu Q, Wang J, et al
    Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT/GSK-3beta/beta-catenin/cyclinD1 signaling pathway.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31112.
    >> Share


    Int J Oncol

  42. ESPINOZA-SANCHEZ NA, Vadillo E, Balandran JC, Monroy-Garcia A, et al
    Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
    Int J Oncol. 2017 Sep 19. doi: 10.3892/ijo.2017.4128.
    >> Share

  43. YANG L, Li Y, Shen E, Cao F, et al
    NRG1-dependent activation of HER3 induces primary resistance to trastuzumab in HER2-overexpressing breast cancer cells.
    Int J Oncol. 2017 Sep 21. doi: 10.3892/ijo.2017.4130.
    >> Share

  44. BORAH N, Gunawardana S, Torres H, McDonnell S, et al
    5,6,7,3',4',5'-Hexamethoxyflavone inhibits growth of triple-negative breast cancer cells via suppression of MAPK and Akt signaling pathways and arresting cell cycle.
    Int J Oncol. 2017 Oct 13. doi: 10.3892/ijo.2017.4157.
    >> Share

  45. CALAF GM, Roy D
    Metastatic genes targeted by an antioxidant in an established radiation- and estrogen-breast cancer model.
    Int J Oncol. 2017 Sep 14. doi: 10.3892/ijo.2017.4125.
    >> Share


    J Clin Oncol

  46. VAN POZNAK C, Somerfield MR, Barlow WE, Biermann JS, et al
    Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update.
    J Clin Oncol. 2017 Oct 16:JCO2017754614. doi: 10.1200/JCO.2017.75.4614.
    >> Share

  47. JEMAL A, Robbins AS, Lin CC, Flanders WD, et al
    Factors That Contributed to Black-White Disparities in Survival Among Nonelderly Women With Breast Cancer Between 2004 and 2013.
    J Clin Oncol. 2017 Oct 16:JCO2017737932. doi: 10.1200/JCO.2017.73.7932.
    >> Share


    J Natl Cancer Inst

  48. VERMA V, Simone CB 2nd, Mishra MV
    Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review.
    J Natl Cancer Inst. 2018;110.
    >> Share

  49. CHOI HJ, Joo HS, Won HY, Min KW, et al
    Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer.
    J Natl Cancer Inst. 2018;110.
    >> Share


    Lancet Oncol

  50. COSTA L, Ferreira AR
    Adjuvant zoledronic acid to treat breast cancer: not for all.
    Lancet Oncol. 2017 Oct 13. pii: S1470-2045(17)30695.
    >> Share

  51. COLEMAN R, Hall A, Albanell J, Hanby A, et al
    Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.
    Lancet Oncol. 2017 Oct 13. pii: S1470-2045(17)30603.
    >> Share


    N Engl J Med

  52. LEMERY S, Keegan P, Pazdur R
    First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
    N Engl J Med. 2017;377:1409-1412.
    >> Share

  53. RAMASWAMI R, Morrow M, Jagsi R
    Contralateral Prophylactic Mastectomy.
    N Engl J Med. 2017;377:1288-1291.
    >> Share


    Nat Rev Clin Oncol

  54. SIDAWAY P
    Breast Cancer: Abemaciclib effective in combination with aromatase inhibition.
    Nat Rev Clin Oncol. 2017 Oct 17. doi: 10.1038/nrclinonc.2017.
    >> Share


    Oncol Rep

  55. HE DX, Wu XL, Lu CX, Gu XT, et al
    Genome-wide analysis of the three-way interplay among gene expression, estrogen receptor expression and chemotherapeutic sensitivity in breast cancer.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6033.
    >> Share

  56. AN J, Wang L, Zhao Y, Hao Q, et al
    Effects of FSTL1 on cell proliferation in breast cancer cell line MDAMB231 and its brain metastatic variant MDAMB231BR.
    Oncol Rep. 2017 Sep 26. doi: 10.3892/or.2017.6004.
    >> Share

  57. TANG CP, Zhou HJ, Qin J, Luo Y, et al
    MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Oncol Rep. 2017 Sep 19. doi: 10.3892/or.2017.5968.
    >> Share

  58. ONO H, Iizumi Y, Goi W, Sowa Y, et al
    Ribosomal protein S3 regulates XIAP expression independently of the NF-kappaB pathway in breast cancer cells.
    Oncol Rep. 2017 Sep 27. doi: 10.3892/or.2017.6008.
    >> Share

  59. ZHANG Y, Wang DL, Yan HY, Liao JY, et al
    Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer.
    Oncol Rep. 2017 Sep 20. doi: 10.3892/or.2017.5975.
    >> Share

  60. ZHAO Y, Ge CC, Wang J, Wu XX, et al
    MEK inhibitor, PD98059, promotes breast cancer cell migration by inducing beta-catenin nuclear accumulation.
    Oncol Rep. 2017 Sep 13. doi: 10.3892/or.2017.5955.
    >> Share

  61. JIANG Y, Ji F, Liu Y, He M, et al
    Cisplatin-induced autophagy protects breast cancer cells from apoptosis by regulating yes-associated protein.
    Oncol Rep. 2017 Oct 16. doi: 10.3892/or.2017.6035.
    >> Share

  62. HAN Y, Zhang L, Wang W, Li J, et al
    Livin promotes the progression and metastasis of breast cancer through the regulation of epithelialmesenchymal transition via the p38/GSK3beta pathway.
    Oncol Rep. 2017 Oct 10. doi: 10.3892/or.2017.6017.
    >> Share

  63. HOU W, Zhang H, Bai X, Liu X, et al
    Suppressive role of miR-592 in breast cancer by repressing TGF-beta2.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6029.
    >> Share

  64. ZHOU T, Zhang A, Kuang G, Gong X, et al
    Baicalin inhibits the metastasis of highly aggressive breast cancer cells by reversing epithelial-to-mesenchymal transition by targeting beta-catenin signaling.
    Oncol Rep. 2017 Sep 28. doi: 10.3892/or.2017.6011.
    >> Share

  65. YANG L, Song Z, Wang X, Yang W, et al
    Huaier extract enhances the treatment efficacy of paclitaxel in breast cancer cells via the NF-kappaB/IkappaBalpha pathway.
    Oncol Rep. 2017 Oct 12. doi: 10.3892/or.2017.6024.
    >> Share


    PLoS One

  66. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    >> Share

  67. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    >> Share

  68. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    >> Share

  69. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    >> Share

  70. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    >> Share

  71. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    >> Share

  72. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    >> Share

  73. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    >> Share

  74. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    >> Share


    Radiology

  75. NGUYEN TL, Choi YH, Aung YK, Evans CF, et al
    Breast Cancer Risk Associations with Digital Mammographic Density by Pixel Brightness Threshold and Mammographic System.
    Radiology. 2017 Oct 16:170306. doi: 10.1148/radiol.2017170306.
    >> Share

  76. FOWLER AM, Mankoff DA, Joe BN
    Imaging Neoadjuvant Therapy Response in Breast Cancer.
    Radiology. 2017;285:358-375.
    >> Share


    Radiother Oncol

  77. CHANG JS, Lee J, Chun M, Shin KH, et al
    Mapping patterns of locoregional recurrence following contemporary treatment with radiation therapy for breast cancer: A multi-institutional validation study of the ESTRO consensus guideline on clinical target volume.
    Radiother Oncol. 2017 Oct 16. pii: S0167-8140(17)32617.
    >> Share


    Science

  78. SPINELLI JB, Yoon H, Ringel AE, Jeanfavre S, et al
    Metabolic recycling of ammonia via glutamate dehydrogenase supports breast cancer biomass.
    Science. 2017 Oct 12. pii: eaam9305. doi: 10.1126/science.aam9305.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016